PULMONX CORP
PULMONX CORP logo
LUNG

PULMONX CORP (LUNG)

$6.081.62%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$5.89
Day's Range
$6.29
$4.07
52-Week Range
$36.37
1 month return21.84%
3 month return68.72%
1 year return82.04%
5 year return84.53%

Company Information

Pulmonx Corporation is a commercial-stage medical technology company. The Company is focused on providing planning tools and treatments for obstructive lung disease. Its solutions include Zephyr Valve, Chartis Pulmonary Assessment System and StratX Lung Analysis Platform. The Company's solutions offer minimally invasive treatment option for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Its solution provides bronchoscopic lung volume reduction without surgery. The Zephyr Valves are indicated for bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valves are placed in the airways to occlude the diseased parts of the lung, allowing trapped air to escape.
OrganizationPULMONX CORP
Employees253
CEOMr. Glendon E. French
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
66%
Buy
33%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for PULMONX CORP(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 114.97%

Current

$6.08

Target

$13.07

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
4
8
8
Hold
2
5
5
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
231.2M
Book Value
$4.37
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.42
Wall Street Target Price
13.07

Valuation

Trailing PE0.0
Forward PE28.33
Price/Book (mrq)
1.49
Enterprise Value
111.8M
Enterprise Value/Revenue
2.15
Enterprise Value/Ebitda
-2.03

Technicals

Beta
0.84
50 Day MA
11.27
200 Day MA
18.21

Institutional Holdings

PRIMECAP Management Company

14.52%

Deerfield Management Co

9.95%

Vanguard Group Inc

8.43%

Champlain Investment Partners, LLC

7.49%

BlackRock Inc

6.6%

Morgan Stanley - Brokerage Accounts

4.96%

Discover more

Frequently Asked Questions

What is PULMONX CORP share price today?

Can Indians buy PULMONX CORP shares?

How can I buy PULMONX CORP shares from India?

Can Fractional shares of PULMONX CORP be purchased?

What are the documents required to start investing in PULMONX CORP stocks?

What are today’s High and Low prices of PULMONX CORP?

What are today’s traded volumes of PULMONX CORP?

What is today’s market capitalisation of PULMONX CORP?

What is the 52 Week High and Low Range of PULMONX CORP?

How much percentage PULMONX CORP is down from its 52 Week High?

How much percentage PULMONX CORP is up from its 52 Week low?

What are the historical returns of PULMONX CORP?

Who is the Chief Executive Officer (CEO) of PULMONX CORP?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*